Status:
COMPLETED
An Adherence Tool to Manage Narcotic -Addicted HIV Patients
Lead Sponsor:
Xhale Assurance
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Healthy Adults
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop a cost-effective breath-based medication adherence monitoring system that can monitor whether recovering opiate addicts actually take a specific treatment medic...
Detailed Description
This study will have two parts. In the first part we will create eight SMART capsule-based naltrexone systems using 4 general types of pharma formulation strategies. Model naltrexone (50mg) formulatio...
Eligibility Criteria
Inclusion
- Ability to understand and provide written informed consent
- Subject is at least 18 Years of Age
- Subject must be willing to comply with study procedures
Exclusion
- \<18 years
- Subject has a history of opioid use disorder
- current chronic opioid therapy or recent (past week) acute opioid therapy,
- currently pregnant
- contraindications to naltrexone use per FDA label.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT02194764
Start Date
June 1 2014
End Date
July 1 2014
Last Update
July 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32611